Skip to content
Clinical Trials – home
Cogent Biosciences Inc.
Sponsor

Cogent Biosciences Inc.

United States 180 3rd Avenue 4th Floor, 02451-7586, United States

About the sponsor

Research activity in gastrointestinal stromal tumor centers on targeted treatment strategies for patients with advanced disease, including combinations with sunitinib and evaluation of tumor control in GIST.

  • Targeted therapy for GIST
  • Sunitinib-based treatment combinations
  • Advanced solid tumor management

The sponsor’s work in this area reflects a focus on molecularly directed options for gastrointestinal stromal tumor treatment.

About Specializations

Cogent Biosciences Inc. runs clinical trials in conditions such as Advanced systemic mastocytosis, Gastrointestinal stromal tumour, Systemic mastocytosis, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

3 clinical trials

Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:3,4-Dimethyl-N-(2-Phenyl-1H-Pyrrolo[2,3-B]Pyridin-5-Yl)-1H-Pyrazole-5-Carboxamide
  • Sponsor:Cogent Biosciences Inc.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Sunitinib
  • Sponsor:Cogent Biosciences Inc.

Systemic mastocytosis

Not recruiting
Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:3,4-Dimethyl-N-(2-Phenyl-1H-Pyrrolo[2,3-B]Pyridin-5-Yl)-1H-Pyrazole-5-Carboxamide
  • Sponsor:Cogent Biosciences Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.